Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

SIRI Levels Following PENG Block in Hip Arthroplasty

3 de novembro de 2026 atualizado por: Poznan University of Medical Sciences

Bloqueio do Grupo Nervoso Pericapsular Mitiga o Stress Cirúrgico e Melhora a Analgesia na Artroplastia Total da Anca: Um Estudo Randomizado Controlado

This randomized controlled trial evaluates the effect of ultrasound-guided Pericapsular Nerve Group (PENG) block on the Systemic Inflammation Response Index (SIRI) in elderly patients undergoing total hip arthroplasty under spinal anesthesia. SIRI, calculated as neutrophil count × monocyte count / lymphocyte count, is used as a composite marker of perioperative inflammatory response. The study investigates whether PENG block attenuates the systemic inflammatory reaction to surgical trauma compared to sham block. The study investigates whether PENG block attenuates the systemic inflammatory reaction to surgical trauma compared to sham block.

Visão geral do estudo

Descrição detalhada

Surgical trauma induces a systemic inflammatory response characterized by neutrophilia, lymphopenia, and platelet activation. These hematologic alterations reflect the interaction between innate immune activation, stress-induced immunosuppression, and pro-thrombotic mechanisms. The modulation of this response may influence postoperative recovery and complication risk.

The Systemic Inflammation Response Index (SIRI) is calculated as neutrophil count × monocyte count / lymphocyte count. It incorporates neutrophils and monocytes in relation to lymphocytes as a composite marker of systemic inflammation. This study evaluates whether PENG block influences postoperative SIRI in patients undergoing total hip arthroplasty.

The primary objective of this study is to compare SIRI at 12 hours after surgery between the PENG block and sham block groups in elderly patients undergoing total hip arthroplasty under spinal anesthesia.

Peripheral venous blood samples will be collected preoperatively and at 12, 24, and 48 hours after surgery. The primary endpoint is SIRI at 12 hours after surgery.

This study aims to determine whether motor-sparing regional anesthesia may modulate systemic inflammatory response beyond analgesic effects, potentially contributing to improved perioperative outcomes.

Tipo de estudo

Intervencional

Inscrição (Real)

60

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

      • Poznan, Polônia, 62-701
        • Poznan University of Medical Sciences

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

65 anos a 100 anos (Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Patients with ASA classification I-III
  • Aged 65-100 years
  • Who will be scheduled for hip arthroplasty under spinal anesthesia

Exclusion Criteria:

  • Patients who have a history of bleeding diathesis
  • Take anticoagulant therapy
  • History of chronic pain before surgery
  • Multiple trauma
  • patients unable to assess their pain (dementia)
  • patients operated under general anesthesia
  • patients having an infection in the region of the procedure
  • the patient who does not accept the procedure

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Quadruplicar

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Comparador Falso: Sham blocks

PENG block with 20ml of 0.9% sodium chloride

After spinal anesthesia, the ultrasound-guided PENG block will be performed with 20ml of 0.9% sodium chloride

Outros nomes:
  • Injeção de cloreto de sódio a 0,9%
Comparador Ativo: PENG block

PENG block with 20ml 0f 0.2% ropivacaine

After spinal anesthesia, the ultrasound-guided PENG block will be performed with 20 ml of 0.2% ropivacaine

Outros nomes:
  • 0,2% de ropivacaína

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Systemic Inflammation Response Index (SIRI)
Prazo: 12 hours after surgery

Systemic Inflammation Response Index (SIRI) is used as a composite marker of systemic inflammatory activation. It is calculated from peripheral venous blood samples using the formula:

SIRI = (Neutrophil count × Monocyte count) / Lymphocyte count All parameters are obtained from routine complete blood count (CBC) analysis and expressed in ×10⁹/L.

SIRI reflects the interaction between innate immune activation (neutrophils and monocytes) and adaptive immune suppression (lymphocytes). Higher SIRI values indicate greater systemic inflammatory response.

12 hours after surgery

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Systemic Inflammation Response Index (SIRI)
Prazo: 24 hours after surgery

Systemic Inflammation Response Index (SIRI) is used as a composite marker of systemic inflammatory activation. It is calculated from peripheral venous blood samples using the formula:

SIRI = (Neutrophil count × Monocyte count) / Lymphocyte count All parameters are obtained from routine complete blood count (CBC) analysis and expressed in ×10⁹/L.

SIRI reflects the interaction between innate immune activation (neutrophils and monocytes) and adaptive immune suppression (lymphocytes). Higher SIRI values indicate greater systemic inflammatory response.

24 hours after surgery
Systemic Inflammation Response Index (SIRI)
Prazo: 48 hours after surgery

Systemic Inflammation Response Index (SIRI) is used as a composite marker of systemic inflammatory activation. It is calculated from peripheral venous blood samples using the formula:

SIRI = (Neutrophil count × Monocyte count) / Lymphocyte count All parameters are obtained from routine complete blood count (CBC) analysis and expressed in ×10⁹/L.

SIRI reflects the interaction between innate immune activation (neutrophils and monocytes) and adaptive immune suppression (lymphocytes). Higher SIRI values indicate greater systemic inflammatory response.

48 hours after surgery
Aggregate Index of Systemic Inflammation (AISI)
Prazo: 12 hours after surgery

Aggregate Index of Systemic Inflammation (AISI) is calculated as:

AISI = (Neutrophil count × Monocyte count × Platelet count) / Lymphocyte count All values are obtained from routine CBC and expressed in ×10⁹/L. AISI integrates neutrophils, monocytes, platelets, and lymphocytes, providing a broader assessment of systemic inflammatory and immune response compared to single ratios.

12 hours after surgery
Aggregate Index of Systemic Inflammation (AISI)
Prazo: 24 hours after surgery

Aggregate Index of Systemic Inflammation (AISI) is calculated as:

AISI = (Neutrophil count × Monocyte count × Platelet count) / Lymphocyte count All values are obtained from routine CBC and expressed in ×10⁹/L. AISI integrates neutrophils, monocytes, platelets, and lymphocytes, providing a broader assessment of systemic inflammatory and immune response compared to single ratios.

24 hours after surgery
Aggregate Index of Systemic Inflammation (AISI)
Prazo: 48 hours after surgery

Aggregate Index of Systemic Inflammation (AISI) is calculated as:

AISI = (Neutrophil count × Monocyte count × Platelet count) / Lymphocyte count All values are obtained from routine CBC and expressed in ×10⁹/L. AISI integrates neutrophils, monocytes, platelets, and lymphocytes, providing a broader assessment of systemic inflammatory and immune response compared to single ratios.

48 hours after surgery
Platelet Mass Index (PMI)
Prazo: 12 hours after surgery

Platelet Mass Index (PMI) reflects total circulating platelet mass and is calculated as:

PMI = Platelet count × Mean Platelet Volume (MPV) Platelet count is expressed in ×10⁹/L and MPV in femtoliters (fL). PMI reflects platelet activation and thrombo-inflammatory potential, which may increase in response to surgical stress.

12 hours after surgery
Platelet Mass Index (PMI)
Prazo: 24 hours after surgery

Platelet Mass Index (PMI) reflects total circulating platelet mass and is calculated as:

PMI = Platelet count × Mean Platelet Volume (MPV) Platelet count is expressed in ×10⁹/L and MPV in femtoliters (fL). PMI reflects platelet activation and thrombo-inflammatory potential, which may increase in response to surgical stress.

24 hours after surgery
Platelet Mass Index (PMI)
Prazo: 48 hours after surgery

Platelet Mass Index (PMI) reflects total circulating platelet mass and is calculated as:

PMI = Platelet count × Mean Platelet Volume (MPV) Platelet count is expressed in ×10⁹/L and MPV in femtoliters (fL). PMI reflects platelet activation and thrombo-inflammatory potential, which may increase in response to surgical stress.

48 hours after surgery
C-reactive Protein (CRP) Concentration
Prazo: 12 hours after surgery

C-reactive protein (CRP) is a laboratory marker of acute systemic inflammation measured in peripheral venous blood samples.

CRP concentration is expressed in mg/L and determined using standard hospital laboratory methods.

Higher CRP values indicate greater postoperative inflammatory response.

12 hours after surgery
C-reactive Protein (CRP) Concentration
Prazo: 24 hours after surgery

C-reactive protein (CRP) is a laboratory marker of acute systemic inflammation measured in peripheral venous blood samples.

CRP concentration is expressed in mg/L and determined using standard hospital laboratory methods.

Higher CRP values indicate greater postoperative inflammatory response.

24 hours after surgery
C-reactive Protein (CRP) Concentration
Prazo: 48 hours after surgery

C-reactive protein (CRP) is a laboratory marker of acute systemic inflammation measured in peripheral venous blood samples.

CRP concentration is expressed in mg/L and determined using standard hospital laboratory methods.

Higher CRP values indicate greater postoperative inflammatory response.

48 hours after surgery
Postoperative Pain Intensity (NRS)
Prazo: 4 hours after surgery

Postoperative pain intensity will be assessed using the Numerical Rating Scale (NRS), ranging from 0 to 10, where:

0 = no pain 10 = worst pain imaginable Pain scores will be recorded at rest.

4 hours after surgery
Postoperative Pain Intensity (NRS)
Prazo: 8 hours after surgery

Postoperative pain intensity will be assessed using the Numerical Rating Scale (NRS), ranging from 0 to 10, where:

0 = no pain 10 = worst pain imaginable Pain scores will be recorded at rest.

8 hours after surgery
Postoperative Pain Intensity (NRS)
Prazo: 12 hours after surgery

Postoperative pain intensity will be assessed using the Numerical Rating Scale (NRS), ranging from 0 to 10, where:

0 = no pain 10 = worst pain imaginable Pain scores will be recorded at rest.

12 hours after surgery
Postoperative Pain Intensity (NRS)
Prazo: 24 hours after surgery

Postoperative pain intensity will be assessed using the Numerical Rating Scale (NRS), ranging from 0 to 10, where:

0 = no pain 10 = worst pain imaginable Pain scores will be recorded at rest.

24 hours after surgery
Postoperative Pain Intensity (NRS)
Prazo: 48 hours after surgery

Postoperative pain intensity will be assessed using the Numerical Rating Scale (NRS), ranging from 0 to 10, where:

0 = no pain 10 = worst pain imaginable Pain scores will be recorded at rest.

48 hours after surgery
Opioid Consumption
Prazo: 48 hours after surgery

Total opioid consumption within the first 48 hours after surgery will be recorded.

All administered opioids will be converted to intravenous morphine milligram equivalents (MME) for standardization.

Higher cumulative MME indicates greater analgesic requirement.

48 hours after surgery
Time to First Rescue Analgesia
Prazo: 48 hours after surgery

Time from completion of surgery to first administration of rescue opioid analgesia.

Measured in minutes. Shorter time indicates earlier breakthrough pain.

48 hours after surgery

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

1 de março de 2026

Conclusão Primária (Real)

30 de setembro de 2026

Conclusão do estudo (Real)

2 de outubro de 2026

Datas de inscrição no estudo

Enviado pela primeira vez

27 de fevereiro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

27 de fevereiro de 2026

Primeira postagem (Real)

4 de março de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

6 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

3 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

SIM

Descrição do plano IPD

De-identified individual participant data (IPD) underlying the results reported in publications (including demographic data, laboratory inflammatory indices such as SII, SIRI, AISI, CRP values, pain scores, opioid consumption, and time-to-event outcomes) will be made available to qualified researchers.

Data will be shared after removal of all direct identifiers in accordance with GDPR regulations and institutional data protection policies.

The study protocol, statistical analysis plan (SAP), and analytic code will also be available upon reasonable request.

Data will be provided for the purpose of secondary analyses, meta-analyses, or validation studies, subject to approval by the principal investigator and institutional review board, where applicable.

Prazo de Compartilhamento de IPD

Data will become available 6 months after publication of the primary results and will remain available for 5 years.

Critérios de acesso de compartilhamento IPD

Access will be granted to researchers who provide:

A methodologically sound research proposal Institutional affiliation Ethical approval (if required) A signed data use agreement Requests should be directed to the principal investigator via institutional email.

Tipo de informação de suporte de compartilhamento de IPD

  • PROTOCOLO DE ESTUDO
  • SEIVA
  • ANALYTIC_CODE

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever